Alto Neuroscience, Inc. Business Finance Contracts & Agreements
9 Contracts & Agreements
- Assignment Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (2)
- Purchase Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (1)
- Warrant Agreements (1)
- Convertible Loan Agreement, by and between the Registrant and The Wellcome Trust Limited, dated as of July 24, 2024 (Filed With SEC on July 29, 2024)
- 2024 Employee Stock Purchase Plan (Filed With SEC on January 29, 2024)
- Form of Common Stock Certificate (Filed With SEC on January 29, 2024)
- Form of Underwriting Agreement (Filed With SEC on January 29, 2024)
- Asset Purchase Agreement, by and between the Registrant and Teva Pharmaceutical Industries, Ltd., dated as of October 4, 2021 (Filed With SEC on January 12, 2024)
- Assignment and Assumption Agreement, by and between the Registrant and Palisade Bio, Inc. (formerly Seneca Biopharma, Inc., formerly Neuralstem Inc.), dated as of October 18, 2021 (Filed With SEC on January 12, 2024)
- Loan and Security Agreement, by and among the Registrant, K2 HealthVentures LLC, as a lender, and the other lenders from time to time party thereto, or collectively the Lender, K2... (Filed With SEC on January 12, 2024)
- Warrant to Purchase Preferred Stock, dated December 16, 2022, issued to K2 HealthVentures Equity Trust LLC (Filed With SEC on January 12, 2024)
- Amended and Restated Investor Rights Agreement, by and among the Registrant and certain of its stockholders, dated as of November 20, 2023 (Filed With SEC on January 12, 2024)
